On April 25th, AstraZeneca announced its financial results for the first quarter of 2024: total revenue was $12.679 billion, a year-on-year increase of 19%; Core earnings per share were $2.06, a year ...

Kanglong Huacheng and AstraZeneca China have reached a strategic cooperation. On May 20th, Kanglong Huacheng announced on its official WeChat account that it has reached a comprehensive strategic coo ...